Dave E, Durrant O, Dhami N, Compson J, Broadbridge J, Archer S
MAbs. 2023; 15(1):2160229.
PMID: 36788124
PMC: 9937000.
DOI: 10.1080/19420862.2022.2160229.
Ghasriani H, Ahmadi S, Hodgson D, Aubin Y
Biomol NMR Assign. 2022; 16(2):391-398.
PMID: 36083574
PMC: 9510101.
DOI: 10.1007/s12104-022-10109-z.
Rashid M
MAbs. 2022; 14(1):2111748.
PMID: 36018829
PMC: 9423848.
DOI: 10.1080/19420862.2022.2111748.
Wang Y, Li X, Chen X, Nielsen J, Petranovic D, Siewers V
Microb Cell Fact. 2021; 20(1):134.
PMID: 34261490
PMC: 8278646.
DOI: 10.1186/s12934-021-01624-0.
Riggs A
Endocr Rev. 2020; 42(3):374-380.
PMID: 33340315
PMC: 8152450.
DOI: 10.1210/endrev/bnaa029.
Bringing the Heavy Chain to Light: Creating a Symmetric, Bivalent IgG-Like Bispecific.
Ramasubramanian A, Tennyson R, Magnay M, Kathuria S, Travaline T, Jain A
Antibodies (Basel). 2020; 9(4).
PMID: 33172091
PMC: 7709125.
DOI: 10.3390/antib9040062.
Surface plasmon resonance (SPR) based binding studies of refolded single chain antibody fragments.
Singh P
Biochem Biophys Rep. 2018; 14:83-88.
PMID: 29872739
PMC: 5986705.
DOI: 10.1016/j.bbrep.2018.04.005.
Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma.
Cahan B, Leong L, Wagman L, Yamauchi D, Shibata S, Wilzcynski S
Cancer Biother Radiopharm. 2017; 32(7):258-265.
PMID: 28910150
PMC: 5646801.
DOI: 10.1089/cbr.2017.2223.
A New Agent in the Strategy to Cure AIDS.
Zaia J
Mol Ther. 2016; 24(11):1894-1896.
PMID: 27916996
PMC: 5154490.
DOI: 10.1038/mt.2016.194.
Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria.
Robinson M, Ke N, Lobstein J, Peterson C, Szkodny A, Mansell T
Nat Commun. 2015; 6:8072.
PMID: 26311203
PMC: 4560801.
DOI: 10.1038/ncomms9072.
Lepidopteran cells, an alternative for the production of recombinant antibodies?.
Cerutti M, Golay J
MAbs. 2012; 4(3):294-309.
PMID: 22531440
PMC: 3355492.
DOI: 10.4161/mabs.19942.
scFv antibody: principles and clinical application.
Ahmad Z, Yeap S, Ali A, Ho W, Mohamed Alitheen N, Hamid M
Clin Dev Immunol. 2012; 2012:980250.
PMID: 22474489
PMC: 3312285.
DOI: 10.1155/2012/980250.
Production of human-mouse chimeric antibody by high cell density perfusion culture.
Takazawa Y, Tokashiki M
Cytotechnology. 2012; 2(2):95-101.
PMID: 22358621
DOI: 10.1007/BF00386141.
Expression of high-affinity human antibody fragments in bacteria.
Rouet R, Lowe D, Dudgeon K, Roome B, Schofield P, Langley D
Nat Protoc. 2012; 7(2):364-73.
PMID: 22301775
DOI: 10.1038/nprot.2011.448.
"Inclonals": IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding system.
Hakim R, Benhar I
MAbs. 2010; 1(3):281-7.
PMID: 20065645
PMC: 2726588.
DOI: 10.4161/mabs.1.3.8492.
High-level production and secretion of a mouse-human chimeric Fab fragment with specificity to human carcino embryonic antigen in Escherichia coli.
Shibui T, Munakata K, Matsumoto R, Ohta K, Matsushima R, Morimoto Y
Appl Microbiol Biotechnol. 1993; 38(6):770-5.
PMID: 7763534
DOI: 10.1007/BF00167143.
Reflections on tumor origin, immunogenicity, and immunotherapy.
Weiss D
Cancer Immunol Immunother. 1984; 18(1):1-4.
PMID: 6386142
PMC: 11039076.
DOI: 10.1007/BF00205391.
Antibody engineering, a strategy for the development of monoclonal antibodies.
Schonherr O, HOUWINK E
Antonie Van Leeuwenhoek. 1984; 50(5-6):597-623.
PMID: 6099095
DOI: 10.1007/BF02386229.
Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene.
Verweij C, de Vries C, Distel B, van Zonneveld A, Van Kessel A, van Mourik J
Nucleic Acids Res. 1985; 13(13):4699-717.
PMID: 3875078
PMC: 321821.
DOI: 10.1093/nar/13.13.4699.
Expression of recombinant immunoglobulin genes to produce novel molecules with specific functions.
Gritzmacher C
Immunol Res. 1986; 5(3):210-20.
PMID: 3553373
DOI: 10.1007/BF02919202.